We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Everolimus

News List

Researchers develop better way to determine safe drug doses for children worldpharmanews
May 11, 2021
Determining safe yet effective drug dosages for children is an ongoing challenge for pharmaceutical companies and medical doctors alike. A new drug is usually first tested on adults, and results from these trials are used to select doses for pediatric ...
NATCO gets US FDA nod for Everolimus tablets expresspharma
March 09, 2021
They are indicated in the treatment of breast cancer and a few other types of cancers.
Two new developments in kidney cancer treatments europeanpharmaceuticalreview
February 19, 2021
Studies suggest there are better treatment options than sunitinib for kidney cancers; cabozantinib in metastatic papillary kidney cancer and lenvatinib/pembrolizumab for renal cell carcinoma.